ADC Therapeutics (ADCT) Stock Price, Quote, News & History | Benzinga

ADC Therapeutics SA (ADCT) Stock Price, Quote, News & History

ADCTNYSE

Trade with Public

Trade with Public

$1.27

0.010.79%

At close: Jul 21, 5:00 PM EST

$1.28

0.010.79%

After Hours: 6:07 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.24

Close

$1.27

Volume / Avg.

861.18K / 1.87M

Day Range

$1.24 - $1.30

52 Wk Range

0.78 - 4.98

Market Cap

$162.80M

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

41

Short Interest

5.56%

Days to Cover

3.4

Recent ADC Therapeutics SA News

These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refinancing deals and short squeezes.

Piero Cingari

This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday

Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.

Avi Kapoor

ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)

U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.67%, other stocks also slide.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-114.55M

Investing Cash Flow (TTM)

627.00K

Financing Cash Flow (TTM)

150.09M

Free Cash Flow (TTM)

-114.58M

Capital Expenditure (TTM)

-32.00K

Net Change in Cash (TTM)

36.17M

Analyst Trends and Forecast

1

Mar

2

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$45.92M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.21

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-76.98%

Earnings Yield % (FWD)

-66.27%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.70

Company Debt

Total Debt

$115.68M

LT Debt

$111.04M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$231.01M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.24

Close

$1.27

Volume / Avg.

861.18K / 1.87M

Day Range

$1.24 - $1.30

52 Wk Range

0.78 - 4.98

Market Cap

$162.80M

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

41

Short Interest

5.56%

Days to Cover

3.4

About

Sector

Health Care

Industry

Biotechnology

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ADC Therapeutics (ADCT) stock?

A

You can purchase shares of ADC Therapeutics (NYSE:ADCT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ADC Therapeutics (ADCT) competitors?

A

There are no as such competitors for ADC Therapeutics.

Q

What is the forecast, or price target, for ADC Therapeutics (ADCT) stock?

A

ADC Therapeutics has a consensus price target of $7.00.

Q

What is the current price for ADC Therapeutics (ADCT)?

A

The stock price for ADC Therapeutics (NYSE: ADCT) is $1.28 last updated July 21, 2026 at 6:07 PM EDT.

Q

Does ADC Therapeutics (ADCT) pay a dividend?

A

There are no upcoming dividends for ADC Therapeutics.

Q

When is ADC Therapeutics (NYSE:ADCT) reporting earnings?

A

ADC Therapeutics does not have any upcoming earnings scheduled.

Q

Is ADC Therapeutics (ADCT) going to split?

A

There is no upcoming split for ADC Therapeutics.

Q

What sector and industry does ADC Therapeutics (ADCT) operate in?

A

ADC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.